HomeLYEL • NASDAQ
Lyell Immunopharma Inc
Follow
$9.15
5.57%
After Hours:(0.00%)0.00
$9.15
Closed: Jul 7, 4:00:08 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Denver Gazette
29 minutes ago
S&P 500, Nasdaq futures inch up as investors focus on trade negotiations
0.79%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.00K | 133.33% |
Operating expense | 56.08M | 0.94% |
Net income | -52.20M | 13.96% |
Net profit margin | -745.64K | 63.13% |
Earnings per share | — | — |
EBITDA | -52.64M | -4.15% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 301.18M | -42.77% |
Total assets | 429.80M | -38.09% |
Total liabilities | 93.28M | 2.43% |
Total equity | 336.52M | — |
Shares outstanding | 14.77M | — |
Price to book | 0.43 | — |
Return on assets | -30.45% | — |
Return on capital | -33.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -52.20M | 13.96% |
Cash from operations | -54.74M | -30.28% |
Cash from investing | 69.47M | 215.84% |
Cash from financing | 1.00K | -96.30% |
Net change in cash | 14.73M | 173.66% |
Free cash flow | -37.53M | -66.52% |
Previous close
$9.69
Day range
$9.11 - $9.64
Year range
$7.65 - $38.40
Market cap
141.21M USD
Avg Volume
234.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
300
